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The adaptive immune response begins when CD4+ T cells recognize antigenic peptides
bound to class II molecules of the Major Histocompatibility Complex (MHCII). The inter-
action between peptides and MHCII has been historically interpreted as a rigid docking
event. However, this model has been challenged by the evidence that conformational flexi-
bility plays an important role in peptide-MHCII complex formation.Thermodynamic analysis
of the binding reaction suggests a model of complexation in which the physical-chemical
nature of the peptide determines the variability in flexibility of the substates in the peptide-
MHC conformational ensemble.This review discusses our understanding of the correlation
between thermodynamics of peptide binding and structural features of the resulting com-
plex as well as their impact on HLA-DM activity and on our ability to predict MHCII-restricted
epitopes.
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EPITOPE SELECTION AS A THERMODYNAMICS-BASED
PROCESS
Upon immunization with a complex antigen, or challenge by a
pathogen, an organism’s CD4+ T cells recognize antigen-derived
peptides bound to MHC class II molecules (MHCII) exposed on
the surface of antigen presenting cells (APCs). A critical feature of
the elicited T cell response is the phenomenon of immunodom-
inance (1). This refers to the evidence that, despite the diversity
of the T cell repertoire, the co-expression of different MHCII alle-
les and the potential generation of a panoply of distinct peptides,
a large proportion of the responding T cells tends to be specific
for a few peptide determinants, known as immunodominant anti-
gens. A relevant observation related to immunodominance is the
evidence that complex antigens have many sequences that can
bind to the MHC molecule and trigger a T cell response if exoge-
nously administered as single peptides. These latter sequences,
which can be recognized only after immunization with the pep-
tide and not after processing of the full protein, are known as
“cryptic.” Efforts have been made to understand the mechanisms
behind these phenomena. Analysis of the antigen processing and
presentation pathway indicates that elements of the epitope selec-
tion process are critical to the generation of the peptide repertoire
presented to T cells (2). MHCII molecules are transported from
the endoplasmic reticulum to the MHCII compartments (MIIC)
as multimeric complexes with the chaperone protein invariant
chain (Ii). Ii stabilizes the nascent MHCII and prevents binding
of other endoplasmic reticulum-resident peptides. Upon arrival
in the MIIC, the Ii molecule is cleaved by proteases, leaving a
low-affinity peptide fragment named class II-associated invari-
ant peptide (CLIP) in the MHCII binding groove. CLIP is then
released to allow peptides derived by endosomal fragmentation of
antigenic proteins to be selected for presentation. Evidence col-
lected thus far in the analysis of immunodominance indicates
that a significant correlation exists between affinity and kinetic
stability of a peptide-MHCII dyad, its density on the surface
of the priming APC and the selection of a responding T cell
repertoire (1, 3, 4).
The multitude of peptides, which can be derived from a pro-
tein, includes a consistent number of low-affinity ligands for a
given MHC allele, as well as peptides with intermediate affinity
and few high-affinity ones. Thus, under an immunodominance-
based model of T cell response, MHCII molecules must reach a
thermodynamic equilibrium in which they are complexed with
the highest affinity binders. Considering that the transit time of
an MHCII through the MIIC is comparable to the dissociation
rate of many low-intermediate affinity peptides, it is difficult to
presuppose that the MHC-binder dyad is able to reach such equi-
librium intrinsically. Rather, one would expect that the majority
of MHC molecules is bound to low-affinity peptides that are in
excess (including CLIP) as a consequence of a kinetic control of the
selection process (5, 6). So what can possibly explain the evidence
of immunodominance? One reasonable hypothesis would be the
existence of mechanisms that can enhance the thermodynamic
control of the peptide-binding process.
HLA-DM (DM) is a MIIC-resident MHCII-like molecule that
plays an important role in MHCII-restricted epitope selection. In
the presence of DM, CLIP removal from the newly synthesized
MHCII is facilitated, and the presented peptide-MHCII repertoire
is skewed in favor of kinetically stable, high-affinity peptide-
MHCII complexes. Based on these well-known effects, DM could
be considered the likeliest factor determining the thermodynamic
equilibrium of the endosomal machinery. In consideration of the
impact of binding energetics on the outcome of epitope selection,
this article will review of the thermodynamics of peptide interac-
tion with MHCII, its correlation to complex structure and how
these relate to DM activity.
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SOME STRUCTURAL BACKGROUND
MHCII binds peptides in a groove defined by a β-sheet floor
and two parallel helical sides. The groove is characterized by
hydrophobic pockets and by a network of H-bonds that can
form between MHCII side chains and the peptide backbone (7).
MHCII show extensive polymorphism predominantly restricted
to the peptide-binding groove. The contacts observed in avail-
able MHCII structures have helped cement an interpretation of
MHCII-peptide-binding specificity based on hydrophobic pocket
structure and charge matching (8). This interpretation reflects
the historical model for explaining specificity of ligand-receptor
interaction, namely the docking mechanism, which relies on struc-
tural rigidity and complementarity of shape (and possibly charge).
The energetic contribution of each interaction – hydrophobic or
H-bonding – has been evaluated by mutating individually sin-
gle anchor residues or individually destabilizing specific H-bonds
(9–11). Attempts have been made to predict peptide affinity by
adding the energetic contribution to binding of each single inter-
action expected to be formed between the peptide and the MHCII.
Indeed, several epitope prediction algorithms have been engi-
neered on the assumption that peptide binding is a rigid, enthalpy-
based process (12–16), but their specificity and sensitivity are
questionable (17–19).
Biochemical and biophysical analyses have indicated an
enhanced conformational heterogeneity or flexibility of the pro-
tein in the absence of a peptide (20–23). Several studies indicated
that MHCII molecules undergo a conformational transition dur-
ing peptide binding or exchange from a heterogenic state to a more
rigid and stable state (21, 24, 25). The latter group of reports sug-
gests that the mechanistic details of the peptide loading process
are more complicated than those provided by a simple enthalpy-
based docking model, and further analysis has confirmed this
(26, 27). The ability to correlate MHCII and peptide structural
rearrangement occurring during the interaction with the ener-
getics of the binding process would provide important insights
into the mechanisms controlling epitope selection. Whereas the
literature concerning the thermodynamic properties of peptide-
MHCII formation and their structural correlates is not extensive,
most published observations indicate that complex formation can
be interpreted as an instance of protein folding, and they will be
reviewed in what follows.
COOPERATIVE EFFECTS IMPACT PEPTIDE BINDING AND
COMPLEX KINETIC STABILITY
The correlation between structural aspects of a peptide-MHCII
complex and its thermodynamic features has been analyzed ini-
tially by thermal denaturation studies. Thermal stability of murine
(28, 29) and human (20, 21, 30) MHCII, both empty and bound
to different peptides at varied pH conditions, indicated that empty
class II molecules have a different structure in terms of helicity as
compared to bound structures. Moreover, binding of peptides with
different length or sequence may result in complexes with differ-
ent structure, and the derived thermodynamic parameters indicate
that affinity of the peptide impacts the folding and unfolding of
the complex.
The question of peptide binding as an instance of protein fold-
ing has been approached in recent times by probing cooperativity
(31). Cooperativity in a multipoint ligand-receptor binding event
is measured when one interaction is affected by other interactions.
A general strategy to probe the occurrence of such a phenomenon
is the mutant cycle approach (32). Mutant cycle analysis has been
performed extensively in other systems to characterize transition
states of folding and folding intermediates. This method consists of
introducing multiple substitutions in the sequence of the reactants
and assessing their binding parameters. If the effect on the binding
free energy of the double (or multiple) mutation is not equal to the
sum of effects of the single mutations, then the residues are coupled
(cooperative). The first analysis of cooperativity with this strategy
was performed on the I-Ad/HA (126–138) system (33, 34). The
I-Ad MHCII protein binds peptides with high-affinity also in the
absence of strong anchor, particularly relying on H-bonds. This
first analysis indicated that the energetic contribution of a given
anchor-pocket interaction is a function of the peptide sequence,
suggesting that the binding energy is indeed distributed across the
peptide, with a significant fraction sequestered in the N-terminal
side of the complex. Whereas the H-bond network showed coop-
erativity, no detectable cooperativity between the anchor-pocket
and H-bonding interactions was observed, even at a short dis-
tance, suggesting that for this allele, encapsulation of peptide side
chains into MHCII pockets is independent and probably upstream
of H-bond formation.
A similar strategy was applied to determine the extent of coop-
erativity the HLA-DR1 (DR1)/HA (306–319) system undergoes
during complex formation or peptide release (35, 36). Several clus-
ters of disruptive mutations have been applied to the peptide or the
peptide and MHC up to a five-mutant construct, and they have evi-
denced cooperative effects in peptide binding to and release from
MHCII. Due to the disruptive nature of the substitutions, cooper-
ativity has been interpreted in terms of lack of folding (i.e., what
is the effect of destabilizing a second interaction on the folding of
the complex once a first interaction has been disrupted?). Coop-
erative effects impact peptide affinity or complex stability in an
exponential fashion (35, 36). Differently than in the case of I-Ad,
energetic coupling was observed between anchor/pocket interac-
tions and H-bonds, when respectively located at opposite sides of
the binding groove. A possible explanation for the different coop-
erativity in the two systems may be related to the evidence that
the two alleles are differentially reliant on sequestration of peptide
hydrophobic side chains into pockets for tight binding. This dis-
crepancy, however, highlights the difficulty of finding a model of
peptide-binding valid for all the class II alleles.
DIFFERENT PEPTIDES BIND WITH DIFFERENT
THERMODYNAMIC STRATEGIES
Analysis of cooperativity has indicated that, prior to the expo-
nential increase phase, an energy window exists, in which coop-
erativity (lack of folding) cannot be measured (35, 36). Within
this window, indicated as compensatory region, peptides with dif-
ferent chemistry can bind with relatively comparable free energy
decrease, though the relative enthalpic and entropic contribu-
tions differ significantly. This phenomenon, known as (isother-
mal) entropy-enthalpy compensation, has been observed in sev-
eral flexible binding systems, in which a decrease (or increase)
in the ability of forming binding interactions (enthalpy) can
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be counterbalanced by the increase (or decrease) of search of
conformational space (37).
Following the spectroscopic interpretation of the interplay
between cooperativity and entropy-enthalpy compensation (38),
important insights have been gained into the correlation between
peptide-MHCII complex structure and thermodynamics (37). As
the interaction between peptides and MHCII molecules can be
considered a ligand-receptor multipoint binding, each single inter-
action leads to a local modification of both structure and energet-
ics. Such local modification can be thermodynamically described
for each point system, which is defined by all the atoms within
the interacting core whose radius is determined by the structural
features of the same protein. While peptide and MHCII mole-
cule interact, each point system will be affected by other point
systems (cooperativity) to an extent proportional to the flexibility
of the molecules and the distance between the two points. Since
the protein and in particular some regions of the binding groove
fluctuate, then the effect of flexibility on energetic coupling of mul-
tiple point interactions is correlated to the range and frequency of
fluctuations, which change as new interactions are established.
Fluctuating interactions are associated with a component energy
and entropy. The enthalpic term of binding energy describes the
stored energy in the protein due to conformational change asso-
ciated with the binding, whereas fluctuations of the entire protein
manifest themselves in the conformational entropy term. As new
point systems are engaged in interactions, the enthalpic contri-
bution to free energy of binding increases. The conformational
change associated with one interaction would facilitate forma-
tion of a new cluster of interaction (positive cooperativity). The
entropic contribution to binding decreases, however, since any new
interaction also restrains conformational flexibility; therefore, the
net gain in binding energy by cooperativity is minimal/null. For
this reason high-affinity peptides cannot be constructed just by
adding more and more sources of binding. Indeed it has been
shown that the same high-affinity peptide binds better in the
absence of an H-bond, as compared to when the same H-bond
is present (37).
Importantly, it was found that the compensatory mechanism
is not absolute, that is increasing in conformational flexibility
consequent to lack of viable interactions between peptide and
MHCII cannot overcome extremely poor enthalpic contributions.
This phenomenon was evidenced by identifying a peptide affinity
limit above which cooperativity (as exaggerated lack of folding)
increased exponentially upon addition of disruptive mutation to
the complex (37).
Thus, within the compensatory region, different peptides
may form a complex with MHCII displaying similar IC50 in
equilibrium-based competition binding assays, or comparable Kd
in titration calorimetry, but with different enthalpic and entropic
contributions. The diversity in thermodynamic strategy adopted
by the system will reflect in the range and frequency of the fluctua-
tions of each point system and the structure of the complex overall.
The consequence is that the macrostate of a complex whose for-
mation is highly enthalpic and whose conformational mobility is
greatly restrained will be a collection of similar peptide-MHCII
dyads where most if not all point systems is engaged in inter-
actions with minimal liability at every point in time. On the
contrary, complexes whose formation is correlated to a smaller
entropic penalty are a collection of dyads whose greater conforma-
tion mobility is attempting to optimize the available interactions
leading, at the same time, to structural variability. This is why pos-
tulating that binding of different peptides to a given MHCII results
in“equal”complexes from thermodynamic and possibly structural
standpoints is not justified, even when the measured affinities are
comparable.
PEPTIDE-MHCII THERMODYNAMICS AND DM FUNCTION
DM function has been object of intense research in the past two
decades, and we have recently gained important, though not con-
clusive, insights into its peptide editing activity. Other articles in
this issue will review structure and editing function of DM, and
only few aspects of DM activity will be highlighted here, which
can be related to a thermodynamic/structural model of epitope
selection.
Understanding DM function requires addressing several ques-
tions: (1) what renders a petide-MHCII complex susceptible to
DM? (2) What is the effect of DM on the complex? (3) How does
DM action result in selective binding of high-affinity peptides?
Recent reports from different groups indicate that DM binds a
short-lived MHCII intermediate whose N-terminal region fea-
tures a specific conformation (39–42). This interaction seems to
result in a stable, long-lived DM-DR complex after full dissocia-
tion of the prebound peptide has occurred (41). Still unclear is
how the DM-labile conformation is generated. Historically, spe-
cific sources of binding energy have been indicated as responsible
for generating DM-labile complexes (43–48), but now it appears
that weakening of both H-bonds and“anchor-pocket” interactions
results in susceptibility to DM (49–53). This latter observation
would be consistent with a distributed model of peptide bind-
ing, where every position, to a different extent, affects the overall
capacity of the peptide to bind, and the conformational flexibility
of the complex. How does the overall binding property of the pep-
tide determine DM susceptibility of the complex? One intriguing
explanation would consider the interplay between compensatory
mechanism and cooperativity as responsible for determining the
probability by which the complex assumes a DM-labile conforma-
tion. Indeed, a complex whose formation is correlated to a smaller
entropic penalty is expected to feature greater conformational
mobility as compared to an isoenergetic complex whose forma-
tion requires a larger enthalpic contribution. As a consequence,
the frequency increases at which regions within the N-terminal
side of those complexes are disengaged from peptide interaction
and are more amenable to DM. One observation in support of
this hypothesis is the evidence that peptide-loaded MHCII con-
formers can be differentially susceptible to DM-mediated peptide
release, and that the generation of the labile isomer is a function
of the affinity of the bound peptide for DR (54), as well as the
respective fraction of entropic contribution to the binding energy
(37). Thus, when looking at the peptide release activity of DM, the
thermodynamic strategy adopted by the peptide to bind seems to
play a crucial role.
DM function needs to be considered in the context of pep-
tide exchange, not only peptide release. The addition of an
exchange peptide to the reaction is a confounding factor to the
www.frontiersin.org October 2013 | Volume 4 | Article 308 | 3
Ferrante Thermodynamics of peptide binding to MHCII
understanding of DM mechanism. Indeed it has been shown that
exchange peptides are not simply replacing freshly dissociated pep-
tides, but they intervene in, and possibly trigger the formation of
a metastable intermediate that also includes the prebound peptide
tethered to the MHCII (36). In particular, the role of the exchange
peptide as “co-factor” in DM-mediated peptide exchange has been
identified through its ability to convert DM-stable into DM-labile
conformers (54).
For the active role played by the exchange peptide during
a displacement reaction, the question of DM-mediated peptide
exchange has been approached in terms of DM effect on the
unfolding of the prebound peptide-MHCII complex and refolding
around exchange peptide (36). When the analysis of cooperativity
was performed in the presence of DM, no cooperativity could be
observed in the release of the prebound peptide, contrasting what
was observed for the intrinsic off-rate (35, 36). This evidence was
interpreted as an indication that, once DM interacts with a com-
plex, it promotes a dramatic disruption of the interactions between
MHCII and the peptide, so that the typical coordinate unfolding
of the intrinsic release cannot be measured. Interestingly, mea-
suring cooperativity for the exchange peptide revealed that the
latter needs to fold into the groove more efficiently than the pre-
bound to displace it, and DM increases the energetic threshold that
the exchange peptide has to overcome to displace the prebound
peptide.
These results, along with structural (41) and molecular
dynamic simulation analysis (55), supports a model in which
DM interacts with complexes featuring a rearranged N-terminal
and stabilizes the binding groove in a receptive state; DM shifts
peptide exchange control from kinetic to thermodynamic. More-
over, DM interaction requires the engagement of MHCII residues,
which would be otherwise elements of point system(s) with
the peptide (39–42). Therefore, peptides are stably bound only
when they effectively compete against DM to interact with DR
residues for access to the N-terminal and if the overall bind-
ing energy is such to reduce the conformational lability. Such
high-affinity, high-enthalpy binding would reverse the conforma-
tional rearrangement required for DM binding, thus leading to
DM dissociation (Figure 1). Further studies are required to assess
the correlation between thermodynamic signature of a peptide-
MHCII complex, its conformational flexibility and susceptibility
to DM-mediated peptide exchange. If confirmed, a similar mech-
anism would explain how the system reaches thermodynamic
FIGURE 1 |Thermodynamic model of peptide binding and DM action.
The probability of a peptide binding to a given HLAII correlates with the
probability of the interplay between cooperativity and compensation (here
indicated as entropic contribution to free energy decrease) resulting in the
optimization of all the available interactions. DM interacts with complexes
featuring residual high entropy, promotes peptide release, and skews the
presented peptide repertoire toward highly enthalpic complexes by
increasing the effective free energy threshold for binding.
equilibrium with high-affinity binders in a timeframe compatible
with epitope selection by the endosomal machinery.
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